SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E4CA88C366A1DB6ACE13B17ED3061C6DBDFA40DB3B10BDDD9D60B1B93F3AE61DD22ED0005F3D094458F2D2912CE68836>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E4CA88C366A1DB6ACE13B17ED3061C6DBDFA40DB3B10BDDD9D60B1B93F3AE61DD22ED0005F3D094458F2D2912CE68836
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E4CA88C366A1DB6ACE13B17ED3061C6DBDFA40DB3B10BDDD9D60B1B93F3AE61DD22ED0005F3D094458F2D2912CE68836
http://www.w3.org/2000/01/rdf-schema#comment
"The class II beta-tubulin isotype seems to be a promising predictive marker of docetaxel activity in the treatment of breast neoplasms."
xsd:string
http://purl.uniprot.org/uniprot/#_0FC319206CCC22B1E7D4782341B45B4750B9BB397A45A0E3BBD72D06BD737F444028C1CD2AA2C0A5076FD19F57B3FADF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E4CA88C366A1DB6ACE13B17ED3061C6DBDFA40DB3B10BDDD9D60B1B93F3AE61DD22ED0005F3D094458F2D2912CE68836
http://purl.uniprot.org/uniprot/A0A384MEE3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E4CA88C366A1DB6ACE13B17ED3061C6DBDFA40DB3B10BDDD9D60B1B93F3AE61DD22ED0005F3D094458F2D2912CE68836
http://purl.uniprot.org/uniprot/#_A0A384MEE3-mappedCitation-12533264
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E4CA88C366A1DB6ACE13B17ED3061C6DBDFA40DB3B10BDDD9D60B1B93F3AE61DD22ED0005F3D094458F2D2912CE68836